Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse
Hematological Oncology · 2024
DOI: 10.1002/hon.3197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematological Oncology, 2024. Verfasst von Paola Ghione und 11 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben.
Abstract (Originalsprache)
In this review focused on lymphoma and the central nervous system (CNS), we summarize recent developments in the management of primary (PCNSL) and secondary CNS lymphoma (SCNSL), treatment of CNS lymphoma in the older population, the neuroradiological assessment of CNS lymphoma and finally highlight the ongoing debate on optimal CNS prophylaxis. The section on PCNSL focuses on the different approaches available for frontline treatment in Europe and the United States and discusses consolidation strategies. We then highlight available strategies to treat PCNSL in the elderly population, an area of unmet need. New therapies aiming at minimizing toxicity and prioritizing quality of life are emerging for these patients. Secondary CNS lymphoma, especially in the relapsed/refractory setting is another area of unmet need, and the efficacy of CAR‐T cell therapy is being explored. We provide an overview of the imaging challenges in the neuroradiological assessment of CNS lymphoma. Finally, the section on CNS prophylaxis summarizes recent findings from large retrospective studies challenging the efficacy of present approaches to prophylaxis in higher‐risk patients with lymphoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Sir Charles Gairdner Hospital and Linear Clinical Research, Nedlands, Western Australia, Australia.
- University Hospital Val D'Hebron, Barcellona, Spain.
- Dana Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.
ORCID-Profile: Paola Ghione
Zitieren
APA
Ghione, P., Lewis, K. L., Bobillo, S., Nayak, L., Schorb, E., Nichelli, L., Ng, A., Savage, K. J., McKay, P., Nastoupil, L., Soussain, C., & Cwynarski, K. (2024). Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse. Hematological Oncology. https://doi.org/10.1002/hon.3197
Vancouver
Ghione P, Lewis KL, Bobillo S, Nayak L, Schorb E, Nichelli L, et al. Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse. Hematological Oncology. 2024. doi:10.1002/hon.3197
BibTeX
@article{Ghione2024,
author = {Ghione, Paola and Lewis, Katharine L and Bobillo, Sabela and Nayak, Laksmi and Schorb, Elisabeth and Nichelli, Lucia and Ng, Andrea and Savage, Kerry J and McKay, Pam and Nastoupil, Loretta and Soussain, Carole and Cwynarski, Kate},
title = {Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse},
journal = {Hematological Oncology},
year = {2024},
doi = {10.1002/hon.3197}
}
EUVIMED